1. Repositório Institucional - INCA
  2. Comunicação
  3. Revistas e Informes
  4. Informe INCA
  5. Informe INCA 2011
  6. Informe INCA 293
Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9613
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.date.accessioned2022-07-28T17:33:08Z-
dc.date.available2022-07-28T17:33:08Z-
dc.date.issued2011-10-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/9613-
dc.subjectAntineoplásicospt_BR
dc.subjectAntineoplastic Agentspt_BR
dc.subjectNeoplasiaspt_BR
dc.subjectNeoplasmspt_BR
dc.titleBrasil e Cuba fecham acordo para produção de novos medicamentos contra o câncerpt_BR
dc.title.alternativeInforme INCA 293pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 293

Files in This Item:
File Description SizeFormat 
Informe INCA 293-9.pdf69.36 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.